GlassScriptPhysician profile
Amy Mcmullen
NPI 1205860954
$19,599.98
in general payments reported to CMS, 2019-2025
84 companies · $3,864 in 2025
The $3,864 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,028 · 2020: $682 · 2021: $2,152 · 2022: $2,902 · 2023: $3,497 · 2024: $3,475 · 2025: $3,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $199 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,619.32 |
| Long Term Medical Supply Or Device Loan | $199.40 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,703.70 | 2019-2025 | Imfinzi, Lynparza, Enhertu |
| Janssen Biotech, INC. | $1,214.16 | 2019-2025 | Rybrevant, Darzalex, Tecvayli |
| Novartis Pharmaceuticals Corporation | $1,165.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $929.26 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $875.05 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $789.40 | 2019-2025 | Opdivo |
| Lilly USA, LLC | $631.81 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $625.59 | 2019-2025 | Venclexta, Itovebi, Phesgo |
| Seagen INC. | $614.64 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Genzyme Corporation | $569.85 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $567.96 | 2019-2025 | Fruzaqla, Iclusig, Ninlaro |
| Amgen INC. | $526.65 | 2019-2023 | Kyprolis, Nplate, Xgeva |
| Daiichi Sankyo INC. | $497.73 | 2019-2025 | Enhertu, Datroway |
| Incyte Corporation | $423.13 | 2021-2025 | Jakafi, Monjuvi, Niktimvo |
| Eisai INC. | $414.66 | 2019-2025 |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $400.99 | 2019-2025 | Cabometyx |
| Astellas Pharma US INC | $389.13 | 2019-2025 | Xtandi, Xospata |
| Gilead Sciences, INC. | $331.29 | 2019-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $320.32 | 2019-2024 | |
| Kite Pharma, INC. | $294.76 | 2020-2025 | Yescarta |
| Rigel Pharmaceuticals, INC. | $270.54 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Array Biopharma INC | $253.93 | 2019-2025 | Mektovi, Braftovi, Xalkori |
| Jazz Pharmaceuticals INC. | $253.78 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $228.12 | 2019-2025 | Ultomiris |
| Abbvie INC. | $227.23 | 2019-2024 | |
| Blueprint Medicines Corporation | $206.31 | 2020-2025 | Ayvakit |
| Taiho Oncology, INC. | $204.86 | 2019-2025 | |
| Tersera Therapeutics LLC | $191.80 | 2021-2024 | Quzyttir, Zoladex |
| Glaxosmithkline, LLC. | $190.16 | 2021-2025 | Jemperli, Ojjaara, Zejula |
| Emd Serono, INC. | $189.94 | 2020-2024 | Tepmetko |
| Acrotech Biopharma INC. | $187.65 | 2021-2024 | Beleodaq |
| Regeneron Healthcare Solutions, INC. | $183.52 | 2019-2025 | Libtayo |
| Celgene Corporation | $183.48 | 2022-2025 | Reblozyl, Opdivo |
| Spectrum Pharmaceuticals INC. | $164.37 | 2023-2025 | Rolvedon |
| Pharmaessentia USA Corporation | $161.56 | 2022-2025 | Besremi |
| Pharmacyclics LLC, An Abbvie Company | $148.84 | 2019-2023 | Epkinly, Imbruvica |
| Aveo Pharmaceuticals, INC. | $145.37 | 2022-2025 | Fotivda |
| Pharmacosmos Therapeutics INC. | $137.22 | 2024-2025 | Monoferric |
| Karyopharm Therapeutics INC. | $136.75 | 2021-2025 | Xpovio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.14 | 2019-2025 | Gilotrif |
| Puma Biotechnology, INC. | $132.24 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $131.50 | 2021-2024 | Tazverik, Onivyde |
| Genmab U.S., INC. | $116.82 | 2024-2025 | Epkinly |
| Adc Therapeutics America, INC. | $113.32 | 2022-2025 | |
| Sobi, INC | $111.44 | 2022-2025 | |
| Stemline Therapeutics INC. | $102.39 | 2019-2025 | Orserdu |
| Deciphera Pharmaceuticals INC. | $99.96 | 2022-2025 | Qinlock, Tgct, Romvimza |
| Servier Pharmaceuticals LLC | $94.44 | 2022-2025 | |
| Organon LLC | $91.56 | 2021-2025 | Ontruzant |
| Coherus Oncology, INC. | $81.63 | 2022-2025 | Loqtorzi |
| Amag Pharmaceuticals, INC. | $74.74 | 2019-2021 | |
| Octapharma USA, INC. | $72.09 | 2023-2024 | Octagam Immune Globulin (Human), Panzyga |
| Mirati Therapeutics, INC. | $69.08 | 2023 | Krazati |
| Accord Healthcare, INC. | $64.17 | 2023-2025 | |
| Caris Mpi, INC. | $63.32 | 2025 | Mi Cancer Seek |
| Morphosys, US INC. | $60.63 | 2022-2023 | Monjuvi |
| Clovis Oncology, INC. | $60.23 | 2019-2022 | |
| Syndax Pharmaceuticals, INC. | $59.94 | 2025 | |
| Apellis Pharmaceuticals, INC. | $57.65 | 2023-2024 | Empaveli |
| Beigene USA, INC. | $55.98 | 2022-2024 | Brukinsa, Tevimbra |
| Beone Medicines USA, INC. | $55.49 | 2025 | Tevimbra |
| Cti Biopharma Corp. | $53.93 | 2023 | Vonjo |
| Sun Pharmaceutical Industries INC. | $51.40 | 2023-2025 | Odomzo, Yonsa |
| Legend Biotech USA INC. | $51.40 | 2025 | Carvykti |
| Fennec Pharmaceuticals, INC. | $48.90 | 2024-2025 | Fyarro, Pedmark |
| Immunogen, INC. | $46.29 | 2023 | Elahere |
| Secura Bio, INC. | $42.09 | 2021-2025 | Copiktra |
| Novocure INC. | $38.45 | 2024-2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Myovant Sciences INC. | $37.21 | 2022 | |
| Dova Pharmaceuticals | $36.76 | 2020-2021 | |
| Sirtex Medical INC | $36.50 | 2022-2024 | Sir-Spheres Microspheres |
| Biocon Biologics INC | $35.19 | 2025 | Ogivri |
| Progenics Pharmaceuticals, INC. | $29.89 | 2023 | Pylarify |
| Immunocore Limited | $29.19 | 2024 | Kimmtrak |
| Sumitomo Pharma America, INC. | $26.74 | 2023 | Orgovyx |
| Recordati_rare_diseases_inc. | $25.79 | 2025 | Enjaymo |
| Epizyme, INC. | $23.37 | 2021 | |
| Roche Diagnostics Corporation | $22.79 | 2021 | |
| Aadi Bioscience, INC. | $20.59 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.33 | 2025 | Danziten |
| Mylan Institutional INC. | $19.96 | 2019 | |
| Advanced Accelerator Applications | $19.68 | 2020 | |
| Verastem, INC. | $14.52 | 2019 | |
| Global Blood Therapeutics, INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
Keytruda $481Enhertu $476Lynparza $430Kisqali $358Imfinzi $339Opdivo $321Cabometyx $287Lenvima $255Rybrevant $242Darzalex $242Epkinly $235Tagrisso $208Adcetris $204Xtandi $202Carvykti $201Tukysa $198Verzenio $186Monjuvi $181Ayvakit $180Imbruvica $173Tecvayli $171Elrexfio $168Jakafi $165Rolvedon $164Bosulif $159Sarclisa $153Jaypirca $153Zepzelca $146Libtayo $145Scemblix $143Talzenna $140Monoferric $137Calquence $131Besremi $129Braftovi $123Mektovi $123Ultomiris $119Venclexta $112Orgovyx $112Vonjo $105Fotivda $104Yescarta $99.48Rezlidhia $98.72Tavalisse $98.72Ibrance $94.67Quzyttir $91.74Fruzaqla $90.72Reblozyl $86.65Erleada $86.47Orserdu $85.64Qinlock $85.56Beleodaq $83.91Xpovio $83.61Pluvicto $79.63Xalkori $79.14Tevimbra $76.61Trodelvy $73.97Talvey $69.15Krazati $69.08Welireg $68.75Ontruzant $68.41Elahere $66.97Jemperli $64.85Camcevi $64.17Kyprolis $63.47Lutathera $63.37Mi Cancer Seek $63.32Retevmo $61.62Enjaymo $61.61Iclusig $56.81Balversa $56.70Inlyta $54.61Gavreto $52.95Ninlaro $52.94Yonsa $51.40Odomzo $51.40Octagam Immune Globulin (Human) $51.30Lorbrena $50.96Altuviiio $50.48Itovebi $48.45Oxbryta $47.48Besponsa $45.76Lonsurf $45.43Inqovi $45.43Zoladex $45.06Empaveli $41.96Tibsovo $41.87Datroway $39.35Tasigna $39.28Ziihera $38.30Akeega $37.13Idhifa $36.61Ojjaara $35.36Ogivri $35.19Alecensa $35.18Phesgo $35.18Tecentriq $35.18Tgct $34.17Romvimza $33.96Keytruda Qlex $33.65
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mcmullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.